|
J Biol Chem, Vol. 275, Issue 10, 6928-6936, March 10, 2000
Reactions of BglI and Other Type II Restriction
Endonucleases with Discontinuous Recognition Sites*
Niall A.
Gormley,
Abigail J.
Bath, and
Stephen E.
Halford
From the Department of Biochemistry, School of Medical Sciences,
University of Bristol, University Walk,
Bristol, BS8 1TD, United Kingdom
 |
ABSTRACT |
Type II restriction enzymes generally recognize
continuous sequences of 4-8 consecutive base pairs on DNA, but some
recognize discontinuous sites where the specified sequence is
interrupted by a defined length of nonspecific DNA. To date, a
mechanism has been established for only one type II endonuclease with a
discontinuous site, SfiI at GGCCNNNNNGGCC (where N is any
base). In contrast to orthodox enzymes such as EcoRV,
dimeric proteins that act at a single site, SfiI is a
tetramer that interacts with two sites before cleaving DNA.
BglI has a similar recognition sequence (GCCNNNNNGGC) to SfiI but a crystal structure like EcoRV.
BglI and several other endonucleases with discontinuous
sites were examined to see if they need two sites for their DNA
cleavage reactions. The enzymes included some with sites containing
lengthy segments of nonspecific DNA, such as XcmI
(CCANNNNNNNNNTGG). In all cases, they acted at individual sites.
Elongated recognition sites do not necessitate unusual reaction
mechanisms. Other experiments on BglI showed that it bound
to and cleaved DNA in the same manner as EcoRV, thus
further delineating a distinct group of restriction enzymes with
similar structures and a common reaction mechanism.
 |
INTRODUCTION |
Type II restriction endonucleases recognize specific sequences in
DNA and cut both strands at fixed locations within or adjacent to the
recognition sequence, in reactions that need only Mg2+ as a
cofactor (1). The value of these enzymes as tools for the analysis and
manipulation of DNA has prompted extensive searches for new enzymes of
this type, and over 3000 have been identified (2). The recognition
sites for most restriction enzymes are palindromic sequences of 4, 6, or 8 consecutive bp.1 Almost
all of the relatively small number of type II enzymes that have been
analyzed to date, with respect to their reaction mechanisms and/or
structures, recognize continuous sequences of this sort: viz.
BamHI, EcoRI, EcoRV, MunI,
PvuII, and TaqI (3-8). All of these examples are
homodimeric proteins that interact symmetrically with their respective
recognition sites so that the two active sites are located on the two
target phosphodiester bonds, one in each strand. The enzyme can then
cut both strands at one site in a single DNA-binding event (9, 10). On
a DNA with two or more sites, they usually act in a distributive manner
(11), catalyzing separate reactions at each site, but they sometimes act processively, translocating to a second site and cutting it before
leaving the DNA (10, 12).
With a few exceptions, the type II restriction enzymes have dissimilar
amino acid sequences (13) but their three-dimensional structures can be
similar to one another (14). For instance, the tertiary fold of
EcoRI is very similar to BamHI (15); likewise EcoRV is similar to PvuII (16), though the
overall structures of EcoRI and EcoRV differ
considerably. The mechanisms of these enzymes also show similarities in
some instances and differences in other instances. For example,
EcoRI and BamHI bind to DNA in the absence of
Mg2+ preferentially at their recognition sites (3, 4, 12). In contrast, under their optimal reaction conditions but for the absence of Mg2+, EcoRV, TaqI, and
several others bind equally well to all DNA sequences (17-20). In the
presence of Mg2+, the latter enzymes still cleave DNA
specifically at their recognition sites (21, 22), but they also need a
divalent metal ion for specific binding; Ca2+ can function
in this respect (7, 8, 23, 24). The similarities and the differences
among the type II restriction enzymes have led to the proposal that
many, including BamHI, can be classified as
EcoRI-like enzymes, whereas many others, including
PvuII and TaqI, can be classified as
EcoRV-like enzymes (10, 14, 20, 22). However, an alternative
view maintains that there is no clear-cut distinction between the
EcoRI- and the EcoRV-like enzymes and that these
enzymes are essentially similar to each other in terms of both
mechanism and core structure (6, 19, 24-26).
The recognition sites for some type II restriction enzymes are not the
continuous sequences of 4-8 consecutive bp noted above, but are
instead discontinuous sequences in which the palindromic elements
recognized by the enzyme are separated by a fixed length of nonspecific
DNA (2). The intervening DNA can be as long as 9 bp, viz.
XcmI (Table I), or as short as 1 bp, viz. HhaII (GANTC). Apart from some early studies on HhaII (27),
SfiI is the only type II enzyme with a discontinuous
recognition site whose reaction mechanism has been analyzed (28-33).
SfiI differs from the orthodox enzymes such as
EcoRV in several ways. First, its recognition site contains
8 specified bp interrupted by 5 bp of nonspecific DNA and thus covers
13 bp (Table I), which is longer than usual for a restriction site
(34). Second, SfiI is a tetramer of identical subunits
instead of the normal dimer. Third, no DNA cleavage arises from the
binding of the tetramer to one recognition site. Instead,
SfiI is only active when bound to two copies of its site. It
displays its optimal activity with two sites on the same DNA, where it
loops out the DNA between the sites; but it can also, albeit less
readily, cleave DNA with one SfiI site by bridging two such
molecules. Fourth, once bound to the two sites, SfiI usually
cuts both strands at both sites before leaving the DNA. Another subset
of the type II enzymes, known as type IIe and typified by
EcoRII and NaeI, also needs two sites for the DNA
cleavage reactions but these differ from SfiI in that they
seem to use one site to activate the reaction at the other site; the
activator DNA is not cleaved (35-37). Nonetheless, concerted cleavage
of two recognition sites in the manner of SfiI has been
noted with both Cfr10I and SgrAI (11, 38). Unlike SfiI, Cfr10I and SgrAI recognize
continuous sequences, R CCGGY and GR CCGGYC, respectively. The 8-bp
site for SgrAI is identical to the 6-bp site for
Cfr10I except for one extra bp at each end.
In this study, the reactions of BglI (39) and several other
restriction enzymes with discontinuous recognition sites (Table I) were
analyzed on plasmids with either one or two target sites, to determine
whether enzymes with elongated sites behave like the orthodox enzymes
or whether they interact with two sites, like SfiI. The
recognition sequence for BglI (40) is identical to that for
SfiI except that it is one bp shorter at each end (Table I),
i.e. the same relationship as that between the
Cfr10I and SgrAI sites. This raises the
possibility that BglI might act concertedly at two sites in
the same way as SfiI. However, the structure of
BglI bound to its recognition sequence was recently determined by x-ray crystallography, and this shows a dimeric protein
bound symmetrically to one DNA duplex (41). Moreover, the DNA
recognition and catalytic functions in each subunit of BglI
are similar to those in EcoRV, though the subunit interface in BglI differs from EcoRV. The amino acid
sequences of BglI and EcoRV are not homologous
(13). In EcoRV, which cleaves GAT ATC as marked, the
recognition/catalytic functions of the two subunits are located almost
opposite each other across the axis of the DNA (42). In contrast, the
recognition/catalytic functions of the two subunits in BglI
are displaced relative to each other along the axis of the DNA, thus
allowing it to recognize two specific segments of DNA separated by 5 bp
of nonspecific DNA (41). The main question posed here is whether
BglI acts like SfiI, as might be expected from
its recognition sequence, or like EcoRV, as might be
expected from its crystal structure.
 |
EXPERIMENTAL PROCEDURES |
Proteins--
BglI endonuclease, purified to
homogeneity (41) by I. Schildkraut and colleagues (New England Biolabs,
Beverly, MA), was a gift from M. Newman (Imperial Cancer Research Fund,
London, UK). Its concentration was determined by the method of Bradford (43) and is given in terms of molarity of the dimeric protein of
Mr 70,000. All other enzymes were purchased from
New England Biolabs; concentrations of the latter are given in terms of
units of enzyme activity, as defined by the supplier.
DNA--
Plasmids pUC19 (44), pBR322 (45), pAT153 (46), and
pNEB193 (New England Biolabs) were manipulated by standard procedures (47). To make pBGL1 (Fig. 1a), pUC19 was cleaved with
EcoRI and KasI, and the large fragment was
purified by electrophoresis prior to the removal of its single strand
extensions with mung bean nuclease and re-circularization with T4 DNA
ligase. To make pML1 (Fig. 1b), pBR322 was cleaved with
EcoRI and HindIII and ligated to a 43-bp duplex
that had single strand extensions that matched an EcoRI
terminus at one end and a HindIII terminus at the other end;
the duplex was made from two self-complementary oligodeoxynucleotides,
both 47 bases long, with recognition sites for Tth111I,
PshAI, and AhdI that each had the same flanking
and intervening sequences as the native site in pBR322. To make pAB2 (Fig. 1c), pNEB193 was cleaved with PstI and
HindIII and ligated to a 25-bp duplex with 4-base single
strand extensions that matched a PstI terminus at one end
and a HindIII terminus at the other end; the duplex was made
from two self-complementary oligonucleotides, of 25 and 33 bases, with
recognition sequences for PflMI, BstXI, and
XcmI. To make pAB3 (Fig. 1c), the small DNA
fragment obtained by cleaving pAB2 with PvuII was cloned at
the SspI site on pAB2; the two copies of the
PvuII fragment present in pAB3 are in inverted orientation.
The plasmids were used to transform recA strains of
Escherichia coli, either XL-blue or HB101 (47). The
transformants were cultured in M9 minimal medium with 1 mCi/l
[methyl-3H]thymidine and the covalently closed
form of the plasmid purified by density gradient centrifugations (48).
The preparations were largely supercoiled monomeric plasmid, with
<10% as either dimeric plasmid or nicked open circle DNA.
DNA Cleavage--
Restriction enzymes were assayed by adding an
aliquot (typically 5 µl) to a 3H-labeled plasmid (5 or 10 nM) in 200 µl of the buffer recommended by the supplier
of the enzyme (or modifications thereof). For BglI, the
aliquots were samples diluted to the requisite concentration in 10 mM Tris·HCl (pH 7.4), 300 mM NaCl, 0.1 mM EDTA, 1 mM DTT, 500 µg/ml bovine serum
albumin, and 50% (v/v) glycerol. For the other enzymes, 1-15 units of
the purchased stocks were added directly to the reactions. At various
times after adding the enzyme, 15-µl samples were removed from the
reaction and mixed immediately with 10 µl of stop mix (21). The
samples were analyzed by electrophoresis through agarose to separate
the supercoiled substrate and each of the reaction products. The
segments of agarose that encompassed the substrate and each product
were dissolved in 5 M sodium perchlorate and analyzed
individually by scintillation counting to yield the concentration of
each form of the DNA at each time point (48, 49). For plasmids with two
recognition sites, the two fragments arising from cleavage at both
sites were counted together to obtain one value for the concentration
of doubly cut DNA. Values of v1 and
v2A, the rates for the utilization of the
one-site and two-site substrates, respectively, were evaluated from the
initial linear decline in the concentration of the supercoiled
substrate with time, whereas v2B, the rate for
cutting the second site on the two-site substrate, was assessed
relative to v2A by the curve-fitting procedure
described previously (11).
DNA Binding--
A 465-bp fragment with one BglI site
was obtained by cleaving pUC19 with AatII and
EcoRI (Fig. 1a). An isogenic 465-bp fragment that
lacked a BglI site was obtained by an
AatII/EcoRI digest of a mutated form of pUC19
where BglI site A, GCCATTCAGGC, had been changed to GCCATTCAGAC by using the
Quikchange Mutagenesis kit (Stratagene) with primers
CGCCATTCAGACTGCGCAACTG and its complement. The fragments were isolated
by electrophoresis through agarose, purified with the Qiagen
gel-purification kit, and labeled by using Klenow polymerase with
[ -32P]dATP and dTTP (47). Varied amounts of
BglI (diluted in binding buffer) were added to the fragments
to give 10-µl samples containing ~50 pM DNA and 0-12.5
nM enzyme. The binding buffers contained the required
concentration of NaCl in either EDTA buffer (50 mM Tris·HCl (pH 7.5), 10 mM -mercaptoethanol, 100 µg/ml
bovine serum albumin, 0.1 mM EDTA) or Ca2+
buffer (the same supplemented with 5 mM CaCl2).
After 20 min at room temperature, loading buffer (5 µl) was added to
each sample, and the samples were applied to 6% polyacrylamide gels
(17). The loading buffer was the same as that for the binding reaction, with either EDTA or CaCl2, augmented in both cases with
40% glycerol and 0.01% (w/v) bromphenol blue. For samples in EDTA,
the gel was prepared and run in 0.089 M Tris base, 0.089 M boric acid, and 2 mM EDTA. For samples with
Ca2+, the gel buffer was as above except for 5 mM CaCl2 in place of the EDTA (23). After
electrophoresis, the radioactivity on the gel was measured with a 400B
PhosphorImager and analyzed by ImageQuant software (Molecular Dynamics,
Sunnyvale, CA).
 |
RESULTS |
DNA Cleavage by BglI--
A comparison of the reactions of a
restriction enzyme on substrates with either one or two recognition
sites can distinguish the following schemes (11): independent reactions
at each site, in the conventional distributive manner for a type II
enzyme; processive reactions, where the enzyme translocates from one
site to another without leaving the DNA; activation by a second site, as proposed for the type IIe enzymes; concerted action at two sites, as
noted with SfiI. A type II enzyme will cleave a supercoiled (SC) plasmid with one site first in one strand to give the open circle
(OC) form of the DNA and then in the other strand, to give the
full-length linear (FLL) form (Fig. 2a). The cutting of both strands is often faster than the dissociation of the enzyme from the
DNA (9, 10), and steady-state reactions then yield none of the OC form
(48). A plasmid with two sites is cleaved by an enzyme that acts
independently at each site in sequential steps, leading first to the
transient formation of FLL DNA as one site is cut and then, after a lag
phase, to the final products cut at both sites, L1 and L2 (Fig.
2b). If the recognition sites on the one-site and two-site
substrates are equally susceptible to the enzyme, then independent
action at each site results in the same steady-state rates for the
utilization of the one- and two-site substrates
(v1 and v2A,
respectively) and for the conversion of the FLL form of the two-site
DNA to L1 and L2 (v2B). If
v2A = v2B, the maximal
amount of FLL DNA formed during the reaction on the two-site substrate
will be 40% of the total DNA. On the other hand, both processive and
concerted reactions yield less of the FLL DNA, whereas an enzyme
employing a second site, either as an activator or for a concerted
reaction, would consume the two-site substrate at a faster rate than
the one-site substrate (11).
To determine which scheme applies to the BglI enzyme, the
kinetics of DNA cleavage were analyzed on plasmids with one or two BglI sites, pBGL1 and pUC19, respectively (Fig.
1a). Under steady-state conditions with lower concentrations of enzyme than DNA (Fig. 2), the rates increased linearly with
increasing concentrations of the enzyme (data not shown), and both
substrates were converted completely to the final products expected
from the cleavage of all BglI sites: FLL DNA from pBGL1 and
L1 and L2 from pUC19. Hence, BglI carries out multiple
catalytic turnovers, as expected for a type II endonuclease (1). The
reaction of BglI on the one-site plasmid yielded none of the
OC DNA and instead progressed directly to the FLL form cut in both
strands (Fig. 2a). BglI thus cleaves both DNA
strands at a single recognition site at rates that are faster than its
dissociation from the cleaved DNA. The two-site substrate was cleaved
in sequential stages; first at one site to give FLL DNA and then, after
a lag phase, at the other site to give L1 and L2 (Fig. 2b).
Moreover, the rate of utilization of the two-site substrate
(v2A = 6.3 ± 0.3 min 1) was
similar to the one-site substrate (v1 = 5.4 ± 0.6 min 1). The BglI endonuclease therefore
cleaves each recognition site in an independent reaction, in the
orthodox manner for a type II enzyme.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 1.
Plasmid substrates. a, pUC19
contains two sites for BglI, marked A and
B. The removal of site A, by deleting the DNA
between the KasI and the EcoRI sites, yielded a
plasmid with only BglI site B, pBGL1.
b, pBR322 has single sites for Tth111I,
PshAI, and AhdI. A plasmid with two sites for
each of these enzymes, pML1, was constructed by inserting an
oligonucleotide duplex of the requisite sequence between the
EcoRI and HindIII sites of pBR322. c,
pNEB193, which lacks PflMI, BstXI, and
XcmI sites, was converted into a plasmid with one site for
each of these enzymes, pAB2; an oligonucleotide duplex with the
requisite sequence was inserted between the PstI and
HindIII sites of pNEB193. The PvuII fragment
spanning the insert (indicated in gray) was then cloned at
the SspI site of pAB2 to yield pAB3, with two sites for
PflMI, BstXI, and XcmI.
|
|

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 2.
BglI on plasmids with
(a) one or (b) two recognition
sites. The drawings indicate the various forms of DNA that can
exist during the reaction of a restriction enzyme on circular DNA with
either (a) one or (b) two recognition sites for
the enzyme. SC, supercoiled substrate; OC, open
circle DNA cleaved in one strand; FLL, full-length linear
DNA cleaved in both strands at one site; L1 and
L2 (only in b), the two linear DNA products from
cleaving both strands at both sites. The reactions contained 0.07 nM BglI endonuclease and 5 nM
3H-labeled DNA (~95% supercoiled) in 50 mM
Tris·HCl (pH 7.9), 100 mM NaCl, 10 mM
MgCl2, and 1 mM DTT, at 37 °C. The DNA in
(a) was pBGL1, which has one BglI site. The DNA
in (b) was pUC19, which has two BglI sites. At
timed intervals after adding the enzyme, samples from the reactions
were quenched with stop mix prior to electrophoresis through agarose.
Individual segments of the gels were then analyzed by scintillation
counting to obtain concentrations of the following forms of the DNA at
each time point sampled during the reaction: , supercoiled substrate
(marked SC on both graphs); , open circle DNA (marked OC); ,
full-length linear DNA (marked FLL); (only in b), total
DNA in the two final products after cutting both sites (marked
L1/2).
|
|
The above experiments with the SC form of pUC19 do not reveal which
BglI site is cleaved to yield the FLL form. The two
BglI sites in pUC19, noted as A and B
(Fig. 1a), are flanked by different sequences, and they also
have different sequences in the 5-bp spacer of nonspecific DNA in the
middle of the site. Restriction activity is often affected by sequences
flanking the recognition site (1), and the activity of SfiI
is also modulated by the sequence of the spacer (32). Hence, one
BglI site in pUC19 may be more susceptible than the other.
To monitor the cleavage of each site, pUC19 was cut with
AlwNI, and the linearized DNA was used as a substrate for
BglI (Fig. 3). The cleavage of
either BglI site on this substrate gives rise to two
fragments but the pair of fragments produced by cutting site
A are distinct from those from cutting B (Fig.
3a). A partial product of 1714 bp scores the fraction of the
DNA cleaved only at A, because this fragment carries an
intact site B. Likewise, a partial product of 2090 bp scores
the fraction cleaved only at B. During the BglI
reaction on the linearized pUC19, both the 1714-bp and 2090-bp partial products were formed transiently and were then devoured as their intact
sites were cleaved (Fig. 3b). The singly cut DNA thus
contains one fraction cleaved only at A and another fraction
cleaved only at B. This shows that BglI must
indeed cleave each site in a separate reaction. However, the transient
for the 1714-bp product reached a higher maximum than that for the
2090-bp product. Hence, BglI site A is cleaved
preferentially to site B, by a factor of ~2.5.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 3.
BglI on linear DNA with two
sites. a, the drawing illustrates the possible products
from a BglI reaction on AlwNI-linearized pUC19, a
2686-bp DNA with two BglI sites marked A and
B. Cleavage at B yields a final product of 596 bp
and a partial product of 2090 bp; the latter is then cleaved at
A to the final products of 1118 and 972 bp. Cleavage at
A yields a final product of 972 bp and a partial product of
1714 bp; the latter is then cleaved at B to the final
products of 596 bp and 1118 bp. b, the reaction contained
0.28 nM BglI and 10 nM
AlwNI-linearized pUC19 in 50 mM Tris·HCl (pH
7.9), 100 mM NaCl, 10 mM MgCl2, and
1 mM DTT, at 37 °C. Samples were withdrawn from the
reaction at timed intervals and added immediately to stop mix.
Subsequent electrophoresis of each sample through agarose separated all
six of the forms of DNA noted in a (not shown), and the
concentrations of each were determined by analyzing individual segments
of the gel in a scintillation counter. The concentrations of the
partial products of 2090 bp ( ) and 1714 bp ( ) are shown.
|
|
DNA Binding by BglI--
Independent reactions at individual
recognition sites are common to both the EcoRI- and the
EcoRV-like enzymes, but in the absence of Mg2+,
to prevent DNA cleavage, the enzymes in each group bind to DNA in
distinctive ways (18). Gel-shift studies on the binding of EcoRV to a 381-bp DNA with one EcoRV site
revealed multiple DNA-protein complexes, due to the association of 1, 2, 3···N molecules of protein/molecule of DNA, where
N is the maximum that can fit onto the DNA (17). The same
series of complexes were also formed at the same protein concentrations
with an isogenic DNA lacking an EcoRV site. In contrast, gel
shift studies with EcoRI had revealed a single DNA-protein complex due to specific binding at the recognition site (12). However,
binding studies with EcoRV in the presence of
Ca2+ as a noncatalytic analogue of Mg2+ gave a
single DNA-protein complex with a DNA carrying an EcoRV site
but no complex with a DNA lacking an EcoRV site (23).
Ca2+ ions thus enhance the binding of EcoRV to
its recognition site and diminish its binding to nonspecific DNA.
To determine whether BglI belongs to either group, its
binding to DNA was examined by the gel shift method in the absence of
divalent metal ions and in the presence of Ca2+; no DNA
cleavage was detected in the presence of Ca2+ (see below).
Two DNA fragments were used: a 465-bp fragment containing one
BglI site and an isogenic 465-bp fragment from which the
BglI site had been removed by changing one bp. The
experiments were carried out initially in buffers containing 100 mM NaCl, the optimum for BglI activity (39).
Under these conditions, the stoichiometric addition of 50 pM BglI protein to 50 pM DNA
resulted in all of the DNA being converted to DNA-protein complexes,
regardless of whether the DNA had a BglI site or whether
Ca2+ was present (data not shown). Hence, no distinction
could be made between the binding of BglI to specific or
nonspecific DNA, with or without Ca2+. In contrast to
EcoRV and to most other restriction enzymes, the affinity of
BglI for DNA in 100 mM NaCl is too high to allow for a KD value to be obtained from the titration
of 50 pM DNA with increasing amounts of protein. However,
many restriction enzymes behave as other DNA-binding proteins in
binding to DNA more weakly at elevated salt concentrations (12, 25). By
raising the NaCl concentration to 200 mM, the affinity of
BglI for DNA was reduced sufficiently to permit such
titrations (Fig. 4).

View larger version (107K):
[in this window]
[in a new window]
|
Fig. 4.
BglI binding to specific and
nonspecific DNA in the absence and presence of Ca2+.
The binding reactions contained 32P-labeled DNA (~0.05
nM), in either EDTA buffer with 200 mM NaCl
(a and b) or Ca2+ buffer with 200 mM NaCl (c and d), and
BglI at one of the following concentrations (from left to
right across the gel, as indicated by the expanding scale); 0, 0.05, 0.1, 0.2, 0.4, 0.8, 1.6, 3.1, 6.3, and 12.5 nM. The DNA in
a and c was the 465-bp
AatII/EcoRI fragment from pUC19, which has one
BglI site. The DNA in b and d was the
465-bp AatII/EcoRI fragment from a derivative of
pUC19, which differs from the above by a single bp change in the
recognition sequence for BglI. After 20 min at room
temperature, the samples were subjected to electrophoresis through
polyacrylamide, and the gels were subsequently analyzed in a
PhosphorImager; the phosphorescence records are shown here.
F marks the electrophoretic mobility of the free DNA.
|
|
The addition of progressively increasing amounts of BglI
protein to the DNA with one BglI site, in a buffer
containing 200 mM NaCl but no divalent metal ions, caused a
progressive reduction in the amount of free DNA present in the binding
mixture (Fig. 4a). However, instead of giving rise to the
single retarded complex that would have been expected if the protein
bound only to its recognition site, a sequential series of complexes
were formed, with successively reduced mobilities. The same series of
complexes were formed with the DNA lacking a BglI site, at
the same concentrations of BglI protein (Fig.
4b). Hence, as with EcoRV (17), BglI
binds to DNA in the absence of divalent metal ions with no detectable preference for its recognition site over the sum of the nonspecific sites on these DNA fragments. The successive complexes with both specific and nonspecific DNA are therefore the 465-bp fragments carrying 1, 2, 3···N molecules of BglI protein
bound at random along the DNA. Because BglI covers ~15 bp
of DNA (41), N 31.
When Ca2+ was present, the addition of increasing amounts
of BglI to the DNA with a BglI site no longer
caused the progressive loss of free DNA. Instead, even in 200 mM NaCl, the DNA was converted stoichiometrically to a
single complex, though additional complexes were formed at higher
concentrations of BglI (Fig. 4c). In contrast, Ca2+ had virtually no effect on the binding of
BglI to the DNA without a BglI site; a
progressive rather than a stoichiometric loss of free DNA was recorded,
together with the formation of multiple complexes at similar protein
concentrations to those in the absence of Ca2+ (Fig.
4d). The initial binding to the DNA with a BglI
site, at a stoichiometric concentration of BglI protein,
must therefore be at the recognition site and the additional complexes
formed at higher concentrations must be due to the further binding of 1, 2, 3···N-1 molecules of BglI protein at
nonspecific sites elsewhere on the DNA.
Metal Ion Specificity of BglI--
DNA cleavage by BglI
was examined with other metal ions in place of Mg2+, to
determine whether BglI interacts with metal ions in the same way as EcoRV. EcoRV has significant activity with
either Co2+ or Mn2+ but no activity with
Ca2+ (5, 49, 50). Its optimal turnover rates with
Co2+ and Mn2+ are, respectively, about one
third and one tenth of that with Mg2+ but it has higher
affinities for Co2+ and Mn2+ than
Mg2+; the maximal reaction rate achievable with
Mg2+ requires a higher concentration of metal ion than is
the case with Co2+ or Mn2+ (5). However, the
substitution of Mg2+ with Mn2+ eradicates most
of the specificity of EcoRV for its recognition sequence
(50). With Mg2+, noncognate sites one bp different from the
recognition site are cleaved at least 106 times more
slowly. With Mn2+, some noncognate sites are cleaved just
six times more slowly than the recognition site. No such loss of
specificity occurs with Co2+ (5).
The activity of BglI with alternative metal ions was
examined first by adding logarithmically increasing concentrations of BglI protein to a plasmid with one BglI site in
the presence of a fixed concentration of a divalent metal ion; the
reactions were stopped after a fixed time, and the DNA was analyzed by
electrophoresis through agarose (Fig. 5).
With Mg2+ as the cofactor, the lowest concentration of
BglI tested was sufficient to convert all of the SC
substrate to FLL DNA, by cleaving the BglI site, and no
further cleavages were detected even at a 1000-fold higher
concentration of BglI. With Mn2+, the lowest
enzyme concentration was insufficient to cleave all of the SC
substrate; a 10-fold increase resulted in all of the SC substrate being
cleaved at its BglI site, but a further 10-fold increase in
the enzyme concentration then produced several smaller fragments of
DNA, because of cleavages at a number of secondary sites (Fig. 5).
Co2+ also failed to give complete cleavage of the SC
substrate at the lowest BglI concentration, though a smaller
fraction of the DNA remained intact than was the case with
Mn2+, but, in contrast to Mn2+,
Co2+ caused no additional cleavages at high enzyme
concentrations. Exactly like EcoRV (5, 50), BglI
cleaves DNA with a high degree of specificity for its recognition
sequence in the presence of either Mg2+ or Co2+
but with a very much lower specificity in the presence of
Mn2+.

View larger version (74K):
[in this window]
[in a new window]
|
Fig. 5.
Specificity of BglI with
alternative metal ions. The reactions, in 50 mM
Tris·HCl (pH 7.9), 100 mM NaCl, and 1 mM DTT,
contained pBGL1 (10 nM), one of the concentrations of
BglI noted below, and one of the following salts (5 mM): MgCl2, lanes 3-6;
MnCl2, lanes 7-11; CoCl2,
lanes 11-14. The concentrations of BglI in
lanes 3-6 were 0.5, 5, 50, and 500 nM,
respectively; likewise in lanes 7-10 and 11-14.
Lane 2 had no BglI. After 1.5 h at 37 °C,
the DNA was treated with SDS (0.2% w/v) and proteinase K (0.2 mg/ml)
for 10 min at 37 °C, extracted with phenol/chloroform, and then
analyzed by electrophoresis through agarose. The mobilities of the SC,
OC, and FLL forms of pBGL1 are marked on the left of the
gel. Lane 1 contained size markers ranging from 250 bp at
the bottom of the gel to 10 kilobases at the top.
|
|
A quantitative analysis of BglI activity with various metal
ions was carried out by measuring steady-state rates for the
utilization of a SC substrate with one BglI site at varied
concentrations of each metal ion (Fig.
6). In these reactions, with the enzyme at a lower concentration than the DNA, only the recognition site is
cleaved (Fig. 5). The turnover rates with Mg2+ increased
linearly as the concentration of MgCl2 was increased from 1 to 5 mM but the rates with both Co2+ and
Mn2+ remained virtually unaltered as the concentrations of
these ions were increased above 1 mM (Fig. 6). Thus, as
with EcoRV (5), BglI has a lower affinity for
Mg2+ than for either Co2+ or Mn2+,
but at high metal-ion concentrations, its turnover rate with Mg2+ exceeds that with Co2+, which in turn
exceeds that with Mn2+. The relative rates with these three
ions (Fig. 6) match the extents of DNA cleavage at the lowest
BglI concentration used above (Fig. 5). No DNA cleavage was
detected with Ca2+, at all concentrations tested (Fig. 6).
However, in experiments similar to those described previously with
EcoRV (49), Ca2+ was found to act as a
competitive inhibitor to Mg2+; the addition of increasing
concentrations of CaCl2 to reactions containing a fixed
concentration of MgCl2 progressively reduced the rate of
DNA cleavage (data not shown).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 6.
Metal ion dependence of DNA cleavage by
BglI. Reactions at 37 °C, in 50 mM
Tris·HCl (pH 7.9), 100 mM NaCl, and 1 mM DTT,
contained BglI (0.5 nM) and pBGL1 (5 nM), with one of the following salts at the concentration
indicated on the x-axis: , MgCl2; ,
CoCl2; , MnCl2; , CaCl2.
Samples were withdrawn from the reactions at varied times and analyzed
as in Fig. 2a. Values for v1 were
measured from the initial linear decline in the concentration of
supercoiled pBGL1 with time.
|
|
Other Restriction Enzymes with Discontinuous Sites--
It has
been suggested that the unusual reaction mechanism of SfiI
is due to its elongated recognition site, which covers 13 bp of DNA
(38). If so, then even though BglI acts independently at
each copy of its recognition site in the orthodox manner for a type II
restriction enzyme, other enzymes with elongated sites may act like
SfiI. As noted above, a comparison of the reaction kinetics
of a restriction enzyme on substrates with either one or two
recognition sites provides a diagnostic test for concerted action at
two recognition sites (11). This test was applied to several type II
restriction enzymes with discontinuous recognition sequences. The
enzymes selected for this analysis were chosen on the basis of
similarities in their recognition sequences (Table I) and, in some instances, on account of
unusual features in their genetic organization. The recognition sites
for Tth111I, PshAI, AhdI, and
DrdI all contain the same specified sequence, GAC···GTC,
but the length of the spacer is different in each case. Likewise, the
recognition sites for PflMI, BstXI, and
XcmI are identical to each other except for the length of
the spacer (Table I). If the mode of action of a restriction enzyme is
determined by the length of the recognition site, then the enzymes with
sites containing relatively short interruptions might be expected to act in the orthodox manner, whereas the enzymes recognizing extended sites covering 13 or more bp might act in unorthodox ways. The latter
applies particularly to XcmI, whose recognition site
contains a 9-bp interruption amid 6 specified bp and thus has an
overall length of 15 bp, the longest known for a type II restriction
enzyme (2). Moreover, three of the endonucleases tested here,
PshAI, AhdI, and XcmI, are from
restriction-modification systems with genetic organizations midway
between the type I and the type II systems (13) and have been termed
type 11/2
systems.2
View this table:
[in this window]
[in a new window]
|
Table I
Recognition sequences
The name, the species of origin, and the recognition sequence (2) for
all of the restriction enzymes examined here are listed. The enzymes
are grouped on the basis of similarities in their recognition
sequences.
|
|
The recognition sites for Tth111I, PshAI, and
AhdI occur once in pBR322 (Fig. 1b), and this
plasmid was used as the one-site substrate for these three enzymes. A
two-site substrate for these enzymes, pML1, was constructed by cloning
into pBR322 a duplex carrying each of these sites (Fig. 1b);
in all three cases, the second copy had the same flanking and
intervening sequences as the site present in pBR322. Similarly, two
plasmids were constructed with either one or two copies of the
recognition sequences for PflMI, BstXI and
XcmI, pAB2 and pAB3, respectively, again with identical
flanking and spacer sequences at each copy (Fig. 1c). For
DrdI, pAT153 (46) and pUC19 (Fig. 1a) were used
as the one-site and two-site substrates, respectively; the single
DrdI site in pAT153 is identical to one of the
DrdI sites in pUC19 but the other DrdI site in
pUC19 has different flanking and spacer sequences. Because
DrdI was the only enzyme of the seven examined here to be
tested on substrates with nonidentical recognition sites, the data with
DrdI are described separately from the other six enzymes.
The rates at which the six enzymes cleaved DNA/unit of enzyme varied
considerably, but in all six cases, the rate for the utilization of the
one-site substrate was virtually the same as that for the two-site
substrate (Table II). Despite each having a discontinuous recognition site, none of these enzymes display the
hallmark property of SfiI, faster cleavage of a two-site
substrate than a one-site substrate (28). Five out of the six enzymes, PshAI, AhdI, PflMI, BstXI,
and XcmI, cleaved their two-site substrates in sequential
steps, with equal kinetics for the two steps; first at one site to give
FLL DNA and then at the other site to give, after an initial lag phase,
the two final products, L1 and L2 (representative data for
XcmI shown in Fig.
7a, other data not shown).
However, the reaction of Tth111I on its two-site substrate yielded less of the FLL DNA than expected for a sequential pathway with
two kinetically equal steps; instead, the final products cut at both
sites were generated directly from the start of the reaction without a
lag phase (Fig. 7b). For both XcmI and
Tth111I, the rates for converting the SC two-site substrate
to FLL DNA (v2A) were evaluated relative to
those for the conversion of FLL DNA to L1 and L2
(v2B), from the rise and fall in the
concentration of FLL DNA during these reactions. For XcmI
(Fig. 7a), the best fit was with a ratio of
v2B:v2A at 0.9; for
Tth111I (Fig. 7b), v2B exceeded
v2A by a factor of 3.
View this table:
[in this window]
[in a new window]
|
Table II
Reaction rates on one-site and two-site substrates
The reactions contained the restriction enzyme at the concentration
noted, in terms of units/ml, and the SC form of the plasmid indicated,
at a concentration of 5 nM, in one of the following buffers
at 37 °C (except for Tth111I, at 65 °C, and
BstXI, at 55 °C). For Tth111I,
PshAI, AhdI, and DrdI, the buffer was
20 mM Tris acetate (pH 7.9), 50 mM potassium
acetate, 10 mM magnesium acetate, 1 mM DTT, and
100 µg/ml BSA. For PflMI and BstXI, the buffer
was 50 mM Tris · HCl (pH 7.9), 100 mM
NaCl, 10 mM MgCl2, 1 mM DTT, and 100 µg/ml BSA. For XcmI, the buffer was 10 mM
Tris · HCl (pH 7.9), 50 mM NaCl, 10 mM
MgCl2, 1 mM DTT, and 100 µg/ml BSA. Samples were
withdrawn from each reaction at varied times (0-120 min) after adding
the enzyme and analyzed as in Fig. 2 to determine the residual
concentration of SC DNA at each time point sampled. Reaction rates
(v1 for the one-site DNA, v2A for
the two-site DNA) were evaluated from the initial linear decline in the
concentration of SC substrate with time and are given in terms of fmol
DNA consumed/min/unit of enzyme.
|
|

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 7.
XcmI and Tth111I
on two-site plasmids. a, the reaction at 37 °C
contained 4 units/ml XcmI and 5 nM pAB3 in 10 mM Tris·HCl (pH 7.9), 50 mM NaCl, 10 mM MgCl2, 1 mM DTT, and 100 µg/ml
bovine serum albumin. b, the reaction at 65 °C contained
12 units/ml Tth111I and 5 nM pUC19 in 20 mM Tris acetate (pH 7.9), 50 mM potassium
acetate, 10 mM magnesium acetate, 1 mM DTT, and
100 µg/ml bovine serum albumin. Samples withdrawn from the reactions
at various times were analyzed as in Fig. 2 to determine the
concentrations of the following forms of the DNA: , supercoiled
substrate (marked SC on both graphs); , open-circle DNA (marked OC);
, full-length linear DNA (marked FLL); , total DNA in the two
final products after cutting both sites (marked L1/2).
|
|
As with BglI (Fig. 2), PshAI, AhdI,
PflMI, BstXI, and XcmI all catalyze
independent reactions at each copy of their respective recognition
sites, in the conventional manner for type II enzymes. For
Tth111I, the diminished yield of FLL DNA during its reaction on a two-site substrate (Fig. 7b) could be due to a
concerted reaction at two recognition sites. If so, then
Tth111I must be able to bridge two sites on different DNA
molecules as readily as two sites on the same DNA, because it cleaved
its one-site and two-site substrates at the same rate (Table II). Even
so, this is a possibility. Though SfiI and SgrAI
act concertedly at two sites, the difference between their reaction
rates on two-site and one-site substrates varies with ionic strength,
and in the absence of added salts, they cleave one-site substrates
almost as fast as two-site substrates (11, 29). Alternatively, the lack
of FLL DNA from the Tth111I reaction on its two-site
substrate could be due to a processive mechanism in which the enzyme
first cleaves one site and then translocates to the second site without departing from the DNA. However, an enzyme that acts processively at
low ionic strength is likely to act distributively at high ionic
strength (10, 12). To distinguish these alternatives, the concentration
of potassium acetate in the reaction buffer for Tth111I was
raised from 50 mM to 200 mM. In contrast to
SfiI at elevated ionic strength (29), Tth111I
still cleaved the one-site substrate at the same rate as the two-site
substrate, but its reaction on the two-site DNA now yielded, in
successive stages, OC DNA cut in one strand, then FLL DNA cut in both
strands at one site and finally the end products cut in both strands at
both sites (data not shown). Tth111I thus shows a high
degree of processivity at low ionic strength but, at high ionic
strength, it cleaves each phosphodiester bond in a separate DNA-binding event.
In contrast, DrdI cleaved its two-site substrate, pUC19,
faster than its one-site substrate, pAT153 (Table II). However, when DrdI was tested against a linear form of pUC19, as described
above with BglI (Fig. 3), almost all of the DNA was cleaved
first at the DrdI site that is distinct from the single site
present in pAT153, and the DrdI site on pUC19 that is
identical to the site on pAT153 was cleaved later on in a separate and
much slower reaction (data not shown). Hence, the reason why
DrdI cleaves pUC19 faster than pAT153 is not because its
needs two recognition sites for its DNA cleavage reaction but rather
because it has a marked preference for a particular site that is
present on pUC19 but is absent from pAT153. The preference presumably
arises from the flanking and/or spacer sequences at that site.
 |
DISCUSSION |
The recognition sites for many type II restriction endonucleases
are discontinuous sequences, containing two symmetrically equivalent
sets of specified bp separated by a defined length of nonspecific DNA
(2; Table I). The enzymes that act at such sites must differ from the
enzymes that recognize continuous sequences, such as BamHI
and EcoRV, at least in the positioning of their DNA
recognition functions. A crystal structure is currently available for
only one type II enzyme with a discontinuous site, BglI
(41). The recognition/catalytic functions of BglI are
similar to those in EcoRV, an enzyme recognizing a
continuous sequence, but are arranged differently because of a
different subunit interface. However, very little was known about the
mode of action of BglI in solution. The only known mechanism
for a type II restriction enzyme with a discontinuous site had been
that for SfiI (28). SfiI is a tetrameric protein
that interacts with two recognition sites before being cleaving DNA
(29-33) and thus differs radically from the conventional restriction
enzymes such as BamHI and EcoRV, dimeric proteins
that act at individual sites (1, 14).
It therefore seemed possible that BglI might behave
similarly to SfiI, particularly given the precedence of
Cfr10I and SgrAI, two enzymes that recognize
sites that are related to each other in the same way as the
BglI and SfiI sites and that both need two copies
of their respective sites for their DNA cleavage reactions (11, 38).
However, the experiments on BglI described here reveal no
sign of the concerted mode of action of SfiI at two recognition sites. Unlike SfiI (29, 31), BglI
does not cleave DNA with two sites faster than DNA with one site, nor
does it convert DNA with two sites directly to the final products cut at both sites (Figs. 2 and 3). Instead, in accord with its crystal structure (41), the properties of BglI in solution are very similar to those of EcoRV.
Each turnover of BglI results in the cleavage of both
strands of the DNA at an individual recognition site, without the
liberation of any of the nicked OC form of the plasmid (Fig. 2). Hence,
as with EcoRI (10) and EcoRV (9), the DNA
cleavage steps in the reaction pathway of BglI must be
faster than the subsequent dissociation of the cleaved DNA, and the
latter is presumably rate-limiting for its turnover on plasmid
substrates. However, individual recognition sites for BglI
display varying susceptibilities to the enzyme; the initial reaction of
BglI on pUC19 occurred mainly at site A rather
than site B (Fig. 3). Surprisingly, the steady-state rate
for the utilization of the one-site substrate, pBGL1 (Fig.
1a), is almost the same as that for pUC19, even though pBGL1
carries site B from pUC19. The selection of site
A over B on pUC19 must therefore be due to a
reduced Km rather than an enhanced
Vmax.
Repressor proteins that recognize discontinuous sequences require the
two half-sites to be oriented in a particular manner and thus often
bind most strongly to sites where the intervening DNA is intrinsically
twisted or bent as appropriate (51, 52). The same should apply here,
because DNA bound to BglI is bent through ~20° and is
undertwisted in the spacer region (41). The sequences at the
BglI sites in pUC19 are as follows: Site A,
TTCGCCATTCAGGCTGC and Site B,
CCAGCCGGAAGGGCCGA (underlined bases denote the
specified sequence). The spacer at the recalcitrant site, B,
has only purines in one strand and only pyrimidines in the other and is
thus likely to possess a less flexible structure than the mixed
purine/pyrimidine sequence in the spacer at site A (53).
Hence, one explanation for the elevated Km at site
B is that more energy is required to convert site
B into the requisite structure for DNA cleavage than is the
case at site A. The different flanking sequences either side
of the 11-bp segments may also contribute to this effect.
The BglI endonuclease binds to DNA (Fig. 4) in a manner that
is essentially identical to EcoRV (17, 23) and to some other enzymes such as TaqI (8, 18), but which is distinct from EcoRI (12). In the absence of divalent metal ions,
BglI shows no detectable preference for its recognition site
over the sum of the nonspecific sequences on the DNA fragments used
here. In the presence of Ca2+, it has a marked preference
for its recognition site over the remainder of the DNA. BglI
and EcoRV are thus very similar to each other in terms of
both DNA-binding behavior and three-dimensional structures.
BamHI and EcoRI are also very similar to each
other in both their DNA-binding properties and their three-dimensional structures but differ from EcoRV in both respects. This
supports the proposal, first made by Barany and colleagues (22), that EcoRV and EcoRI represent distinct groups of type
II restriction enzymes (10, 14, 20), in contrast to the view that no
clear-cut distinction can be made between the groups (6, 19,
24-26).
The affinity of BglI for its recognition site in the
presence of Ca2+ is, however, much higher than that of
EcoRV for its site. Because 50 pM concentrations
of both BglI and DNA resulted in the protein binding to all
of the DNA with the BglI site (Fig. 4c), the
KD of BglI for its recognition site
in 200 mM NaCl must be 50 pM. In
contrast, the KD of EcoRV for its
recognition site in a buffer containing Ca2+ and 100 mM NaCl is ~200 pM (23). The difference in
KD values is probably not due to the overall
length of the recognition site for BglI, 11 bp, compared
with that for EcoRV, 6 bp. Though BglI interacts
with the sugar-phosphate backbone of the DNA in both the 5-bp spacer
and in the 2 bp of flanking DNA either side of the site,
EcoRV makes more backbone contacts with the flanking DNA
than BglI (41, 42). The total length of DNA contacted by
EcoRV is similar to that for BglI, 14 versus 15 bp. On the other hand, BglI makes a
larger number of direct interactions with the bases in its target
sequence, contacting all 12 bases in its 6-bp target, than is the case
with EcoRV, where only 8 out of the 12 bases are contacted
directly. Alternatively, the relative affinities of BglI and
EcoRV for their respective recognition sites may be due to
the BglI site undergoing a modest deformation from B-form
DNA on binding to the protein (41), whereas the EcoRV site
undergoes a radical distortion (42). Hence, the fraction of the
intrinsic binding energy used to deform the DNA may be larger with
EcoRV than with BglI. The affinity of
BglI for nonspecific DNA in both the absence and presence of
Ca2+ is also higher than that of EcoRV. This
might account for why Ca2+ ions fail to suppress
BglI binding to nonspecific DNA (Fig. 4d), even
though it suppresses nonspecific binding by EcoRV (23).
BglI responds to alternative metal ions as substitutes for
Mg2+ (Figs. 5 and 6) identically to EcoRV (5,
49, 50). Hence, the roles of the metal ions in DNA recognition and
catalysis by BglI are likely to be the same as in
EcoRV. The crystal structures of EcoRV and
BglI bound to their respective recognition sites in the
presence of divalent metal ions both reveal two metal ions adjacent to
the scissile phosphodiester bond at each active site but not in
identical positions (16, 41). In BglI, the metal ions are
aligned parallel to the axis of the DNA, as in a general mechanism for
phosphodiester hydrolysis with two metal ions (54), whereas the metal
ions in EcoRV are aligned more or less perpendicular to the
axis of the DNA. However, neither structure denotes the active complex.
The structure for BglI used Ca2+ as a
noncatalytic cofactor. Because Ca2+ acts as a competitive
inhibitor of Mg2+ in DNA cleavage by BglI, it is
likely to occupy the same sites as Mg2+ but in a distorted
geometry, due to its larger ionic radius. The structures for
EcoRV used Mg2+, Mn2+,
Co2+, and Ca2+, but even when catalytically
competent metals were soaked into the DNA-protein crystals, no DNA
cleavage ensued. Moreover, in a structure of the enzyme-product complex
for EcoRV generated by crystallizing the complex after DNA
cleavage in solution, the two metal ions and the phosphate from the
scissile bond are positioned differently from their locations in the
enzyme-substrate complex (16). Catalysis by EcoRV may take
place within a structure more like the crystal structure of the
enzyme-product complex than the crystal structure of the
enzyme-substrate complex (5, 55, 56). If this scheme for phosphodiester
hydrolysis by EcoRV is to be applied to BglI, the
active site in BglI would also have to be reorganized prior
to catalysis.
In addition to BglI, seven other restriction enzymes with
discontinuous recognition sites were tested against plasmids with either one or two copies of their sites (Table II). None of the enzymes
needed two copies of their recognition sites for their DNA cleavage
reactions. Hence, enzymes with unusual recognition sites, in which the
specified sequence is interrupted by a defined length of nonspecific
DNA, do not necessarily follow unusual reaction mechanisms, even when
the site is elongated to the extent of the XcmI site. For
six of these enzymes, PshAI, AhdI,
DrdI, PflMI, BstXI, and
XcmI, each recognition site was cleaved in a separate reaction in the orthodox fashion for type II restriction enzymes. By
analogy with the crystal structure of BglI (41), perhaps restriction enzymes whose target sites differ only in the length of the
spacer DNA, such as PflMI, BstXI, and
XcmI (Table I), possess common structures for DNA
recognition but different dimer interfaces, so that the recognition
elements are separated in each case by the appropriate distance. The
seventh, Tth111I, utilized a substrate with one site at the
same rate as the two-site substrate, but it acted processively on the
latter and generally cleaved both sites before departing from the DNA,
at least at the ionic strength of its standard reaction buffer (Fig.
7b). In a survey of restriction enzymes with 8-bp
recognition sites (11), AscI was the only one out of 12 tested, across sites separated by ~700 bp, that acted in a processive
manner. The processivity of Tth111I is, however, remarkable
because the two Tth111I sites on its two-site substrate are
separated by over 2100 bp, almost as far as is possible given the
circumference of pBR322 (Fig. 1b). The ability of
Tth111I to translocate over considerable distances of DNA
might be due to the fact that it is assayed at 65 °C but comes from
an organism that is grown at 75 °C (57). At temperatures below its
optimum for DNA cleavage, SfiI dissociates from the cleaved
DNA at extremely slow rates (31). Hence, Tth111I may also
dissociate from DNA very slowly at its subphysiological temperature of
65 °C.
The enzymes examined here represent only a small fraction of the type
II restriction enzymes with discontinuous sites that have been
identified to date (2). Hence, even though concerted action at two
sites is clearly not obligatory for such enzymes, other type II enzymes
with discontinuous sites may still behave like SfiI. Indeed,
other sorts of restriction-modification systems encode endonucleases
that utilize two copies of a discontinuous site. For example,
BcgI typifies a group of restriction enzymes that cleave DNA
on both sides of a discontinuous recognition site (58). Efficient
cleavage by BcgI requires two such sites on the same DNA
(59). The recognition sites for the type I restriction-modification systems are also bipartite sequences (60). The type I endonucleases cleave DNA at loci distant from their recognition sites, but although the tracking from a single site on a circular DNA can result in DNA
cleavage, virtually no cleavage occurs on a linear DNA with a single
site (61). Three of the endonucleases tested here, PshAI,
AhdI, and XcmI, are from type 11/2
restriction-modification systems.2 The modification genes
of these systems are like those from type I systems, whereas their
restriction genes are like those from type II systems. In all three
cases, the endonucleases from the type 11/2 systems acted at
individual sites in independent reactions, in exactly the same manner
as the conventional type II restriction enzymes such as BglI
and EcoRV.
 |
ACKNOWLEDGEMENTS |
We thank Michael Livingstone, Susan Milsom,
Matthew Newman, Ira Schildkraut, Mark Watson, and Geoff Wilson for aid
and advice.
 |
FOOTNOTES |
*
This work was supported by Grants 7/G10881 and 046178 from
the Biotechnology and Biological Sciences Research Council and the
Wellcome Trust.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 44-117-928-7429;
Fax: 44-117-928-8274; E-mail: s.halford@bris.ac.uk.
2
G. Wilson, personal communication.
 |
ABBREVIATIONS |
The abbreviations used are:
bp, base pair(s);
DTT, dithiothreitol;
SC, supercoiled;
OC, open circle;
FLL, full-length
linear;
L1 and L2, linear DNA fragments from the cleavage of a circular
DNA with two sites at both sites.
 |
REFERENCES |
| 1.
|
Roberts, R. J.,
and Halford, S. E.
(1993)
in
Nucleases
(Linn, S. M.
, Lloyd, R. S.
, and Roberts, R. J., eds)
, pp. 35-88, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 2.
|
Roberts, R. J.,
and Macelis, D.
(1999)
Nucleic Acids Res.
26,
312-313
|
| 3.
|
Dorner, L. F.,
Bitinaite, J.,
Whitaker, R. D.,
and Schildkraut, I.
(1999)
J. Mol. Biol.
285,
1515-1523[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Lesser, D. R.,
Kurpiewski, M. R.,
Waters, T.,
Connolly, B. A.,
and Jen-Jacobson, L.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
7548-7552[Abstract/Free Full Text]
|
| 5.
|
Baldwin, G. S.,
Sessions, R. B.,
Erskine, S. G.,
and Halford, S. E.
(1999)
J. Mol. Biol.
288,
87-104[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Deibert, M.,
Grazulis, S.,
Janulaitis, A.,
Siksnys, V.,
and Huber, R.
(1999)
EMBO J.
21,
5805-5816[CrossRef]
|
| 7.
|
Nastri, H. G.,
Evans, P. D.,
Walker, I. H.,
and Riggs, P. D.
(1997)
J. Biol. Chem.
272,
25761-25767[Abstract/Free Full Text]
|
| 8.
|
Cao, W.
(1999)
Biochemistry
38,
8080-8087[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Erskine, S. G.,
Baldwin, G. S.,
and Halford, S. E.
(1997)
Biochemistry
36,
7567-7576[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Wright, D. J.,
Jack, W. E.,
and Modrich, P.
(1999)
J. Biol. Chem.
274,
31896-31902[Abstract/Free Full Text]
|
| 11.
|
Bilcock, D. T.,
Daniels, L. E.,
Bath, A. J.,
and Halford, S. E.
(1999)
J. Biol. Chem.
274,
36379-36386[Abstract/Free Full Text]
|
| 12.
|
Terry, B. J.,
Jack, W. E.,
and Modrich, P.
(1985)
J. Biol. Chem.
260,
13130-13137[Abstract/Free Full Text]
|
| 13.
|
Wilson, G. G.,
and Murray, N. E.
(1991)
Annu. Rev. Genet.
25,
585-627[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Aggarwal, A. K.
(1995)
Curr. Opin. Struct. Biol.
5,
11-19[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Newman, M.,
Strzelecka, T.,
Dorner, L. F.,
Schildkraut, I.,
and Aggarwal, A. K.
(1994)
Nature
368,
660-664[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Kostrewa, D.,
and Winkler, F. K.
(1995)
Biochemistry
34,
683-696[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Taylor, J. D.,
Badcoe, I. G.,
Clarke, A. R.,
and Halford, S. E.
(1991)
Biochemistry
30,
8743-8753[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Zebala, J. F.,
Choi, J.,
and Barany, F.
(1992a)
J. Biol. Chem.
267,
8097-8105[Abstract/Free Full Text]
|
| 19.
|
Lagunavicius, A.,
Grazulis, S.,
Balciunaite, E.,
Vainius, D.,
and Siksnys, V.
(1997)
Biochemistry
37,
11903-11099
|
| 20.
|
Erskine, S. G.,
and Halford, S. E.
(1998)
J. Mol. Biol.
275,
759-772[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Taylor, J. D.,
and Halford, S. E.
(1989)
Biochemistry
28,
6198-6207[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Zebala, J. F.,
Choi, J.,
Trainor, J.,
and Barany, F.
(1992b)
J. Biol. Chem.
267,
8106-8116[Abstract/Free Full Text]
|
| 23.
|
Vipond, I. B.,
and Halford, S. E.
(1995)
Biochemistry
34,
1113-1119[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Martin, A. M.,
Horton, N. C.,
Lusetti, S.,
Reich, N. O.,
and Perona, J. J.
(1999)
Biochemistry
38,
8430-8439[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Engler, L. E.,
Welch, K. K.,
and Jen-Jacobson, L.
(1997)
J. Mol. Biol.
269,
82-101[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Pingoud, A.,
and Jeltsch, A.
(1997)
Eur. J. Biochem.
246,
1-22[Medline]
[Order article via Infotrieve]
|
| 27.
|
Kaddurah-Daouk, R.,
Cho, P.,
and Smith, H. O.
(1985)
J. Biol. Chem.
260,
15345-15351[Abstract/Free Full Text]
|
| 28.
|
Wentzell, L. M.,
Nobbs, T. J.,
and Halford, S. E.
(1995)
J. Mol. Biol.
248,
581-595[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Nobbs, T. J.,
and Halford, S. E.
(1995)
J. Mol. Biol.
252,
399-411[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Szczelkun, M. D.,
and Halford, S. E.
(1996)
EMBO J.
15,
1460-1469[Medline]
[Order article via Infotrieve]
|
| 31.
|
Nobbs, T. J.,
Szczelkun, M. D.,
Wentzell, L. M.,
and Halford, S. E.
(1998)
J. Mol. Biol.
281,
419-432[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Wentzell, L. M.,
and Halford, S. E.
(1998)
J. Mol. Biol.
281,
433-444[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Embleton, M. L.,
Williams, S. A.,
Watson, M. A.,
and Halford, S. E.
(1999)
J. Mol. Biol.
289,
785-797[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Qiang, B-Q.,
and Schildkraut, I.
(1984)
Nucleic Acids Res.
12,
4507-4516[Abstract/Free Full Text]
|
| 35.
|
Yang, C. C.,
and Topal, M. D.
(1992)
Biochemistry
31,
9657-9664[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Gabbara, S.,
and Bhagwat, A. S.
(1992)
J. Biol. Chem.
267,
18623-18630[Abstract/Free Full Text]
|
| 37.
|
Reuter, M.,
Kupper, D.,
Meisel, A.,
Schroeder, C.,
and Krüger, D. H.
(1998)
J. Biol. Chem.
273,
8294-8300[Abstract/Free Full Text]
|
| 38.
|
Siksnys, V.,
Skirgaila, R.,
Sasnauskas, G.,
Urbanke, C.,
Cherny, D.,
Grazulis, S.,
and Huber, R.
(1999)
J. Mol. Biol.
291,
1105-1118[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Lee, Y. H.,
and Chirikjian, J. G.
(1979)
J. Biol. Chem.
254,
6838-6841[Abstract/Free Full Text]
|
| 40.
|
Bickle, T. A.,
and Ineichen, K.
(1980)
Gene (Amst.)
9,
205-212[Medline]
[Order article via Infotrieve]
|
| 41.
|
Newman, M.,
Lunnen, K.,
Wilson, G.,
Greci, J.,
Schildkraut, I.,
and Phillips, S. E. V.
(1998)
EMBO J.
17,
5466-5476[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Winkler, F. K.,
Banner, D. W.,
Oefner, C.,
Tsernoglou, D.,
Brown, R. S.,
Heathman, S. P.,
Bryan, R. K.,
Martin, P. D.,
Petratos, K.,
and Wilson, K. S.
(1993)
EMBO J.
12,
1781-17945[Medline]
[Order article via Infotrieve]
|
| 43.
|
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Yanisch-Perron, C.,
Viera, C.,
and Messing, J.
(1985)
Gene (Amst.)
33,
103-119[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Bolivar, F.,
Rodriguez, R. L.,
Greene, P. J.,
Betlach, M. C.,
Heyneker, H. L.,
Boyer, H. W.,
Crosa, J. H.,
and Falkow, S.
(1977)
Gene (Amst.)
2,
95-113[Medline]
[Order article via Infotrieve]
|
| 46.
|
Twigg, A. J.,
and Sherratt, D. J.
(1980)
Nature
283,
216-218[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Sambrook, J. C.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 48.
|
Halford, S. E.,
and Goodall, A. J.
(1988)
Biochemistry
27,
1771-1777[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Vipond, I. B.,
Baldwin, G. S.,
and Halford, S. E.
(1995)
Biochemistry
34,
697-704[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Vermote, C. L. M.,
and Halford, S. E.
(1992)
Biochemistry
31,
6082-6089[CrossRef][Medline]
[Order article via Infotrieve]
|
| 51.
|
Koudelka, G. B.,
Harbury, P. H.,
Harrison, S. C.,
and Ptashne, M.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
4633-4637[Abstract/Free Full Text]
|
| 52.
|
Gartenberg, M. R.,
and Crothers, D. M.
(1988)
Nature
333,
824-829[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Travers, A. A.
(1991)
Curr. Opin. Struct. Biol.
1,
114-122[CrossRef]
|
| 54.
|
Steitz, T. A.
(1993)
Curr. Opin. Struct. Biol.
3,
31-38
|
| 55.
|
Stanford, N. P.,
Halford, S. E.,
and Baldwin, G. S.
(1999)
J. Mol. Biol.
288,
105-116[CrossRef][Medline]
[Order article via Infotrieve]
|
| 56.
|
Thomas, M. P.,
Brady, R. L.,
Halford, S. E.,
Sessions, R. B.,
and Baldwin, G. S.
(1999)
Nucleic Acids Res.
27,
3438-3445[Abstract/Free Full Text]
|
| 57.
|
Shinomiya, T.,
and Sato, S.
(1980)
Nucleic Acids Res.
8,
43-56[Abstract/Free Full Text]
|
| 58.
|
Kong, H.,
Roemer, S. E.,
Waite-Ress, P. A.,
Benner, J. S.,
Wilson, G. G.,
and Nwankwo, D. O.
(1994)
J. Biol. Chem.
269,
683-690[Abstract/Free Full Text]
|
| 59.
|
Kong, H.,
and Smith, C. L.
(1998)
Biol. Chem.
379,
605-609[Medline]
[Order article via Infotrieve]
|
| 60.
|
Bickle, T. A.
(1993)
in
Nucleases
(Linn, S. M.
, Lloyd, R. S.
, and Roberts, R. J., eds)
, pp. 89-109, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 61.
|
Szczelkun, M. D.,
Dillingham, M. S.,
Janscak, P.,
Firman, K.,
and Halford, S. E.
(1996)
EMBO J.
15,
6335-6347[Medline]
[Order article via Infotrieve]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. R. Coffin and N. O. Reich
Escherichia coli DNA Adenine Methyltransferase: THE STRUCTURAL BASIS OF PROCESSIVE CATALYSIS AND INDIRECT READ-OUT
J. Biol. Chem.,
July 3, 2009;
284(27):
18390 - 18400.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T.-J. Su, M. R. Tock, S. U. Egelhaaf, W. C. K. Poon, and D. T. F. Dryden
DNA bending by M.EcoKI methyltransferase is coupled to nucleotide flipping
Nucleic Acids Res.,
June 7, 2005;
33(10):
3235 - 3244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chandrashekaran, M. Saravanan, D. R. Radha, and V. Nagaraja
Ca2+-mediated Site-specific DNA Cleavage and Suppression of Promiscuous Activity of KpnI Restriction Endonuclease
J. Biol. Chem.,
November 26, 2004;
279(48):
49736 - 49740.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Gowers, S. R.W. Bellamy, and S. E. Halford
One recognition sequence, seven restriction enzymes, five reaction mechanisms
Nucleic Acids Res.,
June 29, 2004;
32(11):
3469 - 3479.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Bath, S. E. Milsom, N. A. Gormley, and S. E. Halford
Many Type IIs Restriction Endonucleases Interact with Two Recognition Sites before Cleaving DNA
J. Biol. Chem.,
February 1, 2002;
277(6):
4024 - 4033.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pingoud and A. Jeltsch
Structure and function of type II restriction endonucleases
Nucleic Acids Res.,
September 15, 2001;
29(18):
3705 - 3727.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Williams and S. E. Halford
SfiI endonuclease activity is strongly influenced by the non-specific sequence in the middle of its recognition site
Nucleic Acids Res.,
April 1, 2001;
29(7):
1476 - 1483.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Soundararajan, Z. Chang, R. D. Morgan, P. Heslop, and B. A. Connolly
DNA Binding and Recognition by the IIs Restriction Endonuclease MboII
J. Biol. Chem.,
January 4, 2002;
277(2):
887 - 895.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|